1 mg Peptide Strength
Each vial contains a labeled strength of 1 mg of IGF-1 LR3.
Dragon Pharma
You will save $52.00
IGF-1 LR3 1 mg
Insulin-Like Growth Factor
- Product: IGF-1 LR3 1 mg
- Active Substance: Insulin-like Growth Factor 1 LR3
- Strength: 1 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$78.00
$130.00
Warehouse :
International
U.S. Domestic
Dragon Pharma Peptide Product
Dragon Pharma IGF-1 LR3 1 mg Overview
Dragon Pharma IGF-1 LR3 is supplied as a lyophilized powder in a 2 mL vial and contains the modified peptide insulin-like growth factor 1 LR3 at a labeled strength of 1 mg. Product specifications, a batch-specific lab report, storage information, and available payment options are provided below.
Lyophilized Powder Form
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
2 mL Vial
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
Published Lab Report
A published lab report from January 2024 provides measured results for the identified batch.
Product Specifications
| Product name | IGF-1 LR3 1 mg |
|---|---|
| Active substance | Insulin-like Growth Factor 1 LR3 |
| Labeled strength | 1 mg/vial |
| Container | 2 mL vial |
| Total labeled content | 1 mg per vial |
| Product form | Lyophilized powder |
| Manufacturer | Dragon Pharma |
Latest Lab Result
The latest published report for the identified batch, dated January 19, 2024, measured 1.05 mg against the stated 1 mg labeled strength.
Open the Lab Reports tab to view the full report and check the batch number associated with the test.
Related Peptide Options
Other peptide options from the same product line include MK-677 25 mg, a growth hormone secretagogue that increases IGF-1 levels through a different mechanism, and MOTS-C 10 mg, a mitochondrial-derived peptide. These products differ in their mechanism of action and research applications.
Published Test Result
Dragon Pharma IGF-1 LR3 1 mg Lab Report
A published lab report for Dragon Pharma IGF-1 LR3 1 mg is provided below with the test date, measured result and reported batch number. The result can be compared directly with the product's labeled strength of 1 mg.
Published Report
January 19, 2024 Laboratory Test
- Label claim
- 1 mg
- Measured result
- 1.05 mg
- Measured vs. label
- 105.00%
- Batch
- #Unknown
- Test date
Science & Research
Understanding IGF-1 LR3
Insulin-like growth factor 1 LR3 (IGF-1 LR3) is a synthetic analogue of naturally occurring IGF-1 with a modified amino acid sequence designed to alter its binding properties. This section provides a brief overview of what is known about this peptide from research literature.
IGF-1 Analogue
IGF-1 LR3 is a modified form of insulin-like growth factor 1. The "LR3" designation refers to the amino acid substitution that reduces binding to IGF-binding proteins, which is intended to prolong its activity in research settings.
Receptor Binding
IGF-1 LR3 binds to the IGF-1 receptor, activating signaling pathways involved in cell growth, proliferation, and metabolism. Its modified structure affects how it interacts with binding proteins.
Research Applications
Preclinical research has investigated IGF-1 LR3 for its potential effects on cell growth, muscle tissue, and metabolic processes. The modified peptide has been studied in laboratory settings for its interactions with the IGF-1 receptor pathway.
Peptide Reconstitution and Use
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Research References
Peer-reviewed research on IGF-1 LR3 is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Important Health Information
IGF-1 LR3 1 mg Safety Information
Peptide research compounds such as IGF-1 LR3 have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of the IGF-1 pathway and does not constitute medical advice.
Limited Clinical Data
IGF-1 LR3 has not been extensively studied in humans. The available safety information comes primarily from preclinical research.
Growth and Proliferation Effects
Compounds that activate the IGF-1 pathway have the potential to affect cell growth and proliferation. The significance of these effects is not fully characterized for IGF-1 LR3.
Injection-Related Risks
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
Metabolic Effects
IGF-1 LR3 may affect glucose metabolism and insulin sensitivity. The potential significance of these effects is not fully understood.
Contraindications
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.
Limited Research
The long-term effects and safety profile of IGF-1 LR3 have not been established in any population. Research on this peptide is still in the early stages.
Conditions That Require Medical Review
Medical advice is particularly important for individuals with diabetes or glucose metabolism disorders, cancer or a history of cancer, cardiovascular disease, or those taking medications that affect blood sugar or hormone levels. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
Tested Sport
IGF-1 and its analogues, including IGF-1 LR3, are prohibited under anti-doping rules in tested sport at all times unless an applicable therapeutic-use exemption has been granted.
The current status and applicable rules can be checked through the World Anti-Doping Agency Prohibited List.
Common Product Questions
Dragon Pharma IGF-1 LR3 1 mg FAQ
Quick answers about IGF-1 LR3 1 mg specifications, the published lab report, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma IGF-1 LR3 1 mg?
Dragon Pharma IGF-1 LR3 1 mg is a lyophilized peptide product containing 1 mg of insulin-like growth factor 1 LR3 per vial. It is supplied in a 2 mL vial for research purposes.
What does LR3 stand for?
LR3 refers to the modified amino acid sequence of the peptide. It is designed to reduce binding to IGF-binding proteins, which is intended to prolong its activity in research settings.
How much peptide is in each vial?
Each vial contains a labeled strength of 1 mg of IGF-1 LR3.
How is the product supplied?
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
What did the lab report show for this product?
The published lab report dated January 19, 2024 measured 1.05 mg against the stated 1 mg labeled strength.
Does the lab report verify every vial?
No. Each report applies to the sample submitted for that specific test and the batch identified in the report. It does not independently verify the content or condition of every individual vial.
How should IGF-1 LR3 be stored?
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, IGF-1 LR3 solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Does IGF-1 LR3 require refrigeration?
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, IGF-1 LR3 solutions typically require refrigeration. Check the product label for specific storage instructions.
How long does IGF-1 LR3 delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy IGF-1 LR3 with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy IGF-1 LR3 1 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is IGF-1 LR3 permitted in tested sport?
IGF-1 and its analogues, including IGF-1 LR3, are prohibited under anti-doping rules in tested sport unless an applicable therapeutic-use exemption has been granted. Current requirements should be checked against the relevant anti-doping rules before competition.
Where can I find more information on IGF-1 LR3?
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.
Related Offers
Lab Tested
Domestic & International
You will save $18.00
-40% OFF
Dragon Pharma, Europe
Melanocortin Peptide (Tanning Research Compound)
- Product: Melanotan 2 10 mg
- Active Substance: Melanotan 2
- Strength: 10 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$27.00
$45.00
Lab Tested
Domestic & International
You will save $26.00
-40% OFF
Dragon Pharma, Europe
Cognitive/Neuroprotective Peptide
- Product: Semax 5 mg
- Active Substance: Semax
- Strength: 5 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$39.00
$65.00
Lab Tested
Domestic & International
NEW
You will save $18.00
-40% OFF
Dragon Pharma, Europe
Copper Peptide / Tissue Research
- Product: GHK-CU 50 mg
- Active Substance: GHK-CU
- Strength: 50 mg/vial
- Container: 2 mL vial
- Manufacturer: Dragon Pharma
$27.00
$45.00